1. Home
  2. ALKS vs HESM Comparison

ALKS vs HESM Comparison

Compare ALKS & HESM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • HESM
  • Stock Information
  • Founded
  • ALKS 1987
  • HESM 2014
  • Country
  • ALKS Ireland
  • HESM United States
  • Employees
  • ALKS N/A
  • HESM N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • HESM Oil & Gas Production
  • Sector
  • ALKS Health Care
  • HESM Energy
  • Exchange
  • ALKS Nasdaq
  • HESM Nasdaq
  • Market Cap
  • ALKS 4.5B
  • HESM 4.3B
  • IPO Year
  • ALKS 1991
  • HESM N/A
  • Fundamental
  • Price
  • ALKS $27.00
  • HESM $37.53
  • Analyst Decision
  • ALKS Buy
  • HESM Buy
  • Analyst Count
  • ALKS 12
  • HESM 5
  • Target Price
  • ALKS $38.55
  • HESM $43.60
  • AVG Volume (30 Days)
  • ALKS 2.0M
  • HESM 1.4M
  • Earning Date
  • ALKS 05-01-2025
  • HESM 04-28-2025
  • Dividend Yield
  • ALKS N/A
  • HESM 7.22%
  • EPS Growth
  • ALKS 3.47
  • HESM 19.71
  • EPS
  • ALKS 2.17
  • HESM 2.49
  • Revenue
  • ALKS $1,557,632,000.00
  • HESM $1,495,500,000.00
  • Revenue This Year
  • ALKS N/A
  • HESM $13.34
  • Revenue Next Year
  • ALKS $4.38
  • HESM $11.09
  • P/E Ratio
  • ALKS $12.27
  • HESM $15.07
  • Revenue Growth
  • ALKS N/A
  • HESM 10.89
  • 52 Week Low
  • ALKS $22.90
  • HESM $32.75
  • 52 Week High
  • ALKS $36.45
  • HESM $44.05
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 28.10
  • HESM 42.35
  • Support Level
  • ALKS $26.76
  • HESM $34.26
  • Resistance Level
  • ALKS $28.03
  • HESM $37.70
  • Average True Range (ATR)
  • ALKS 1.35
  • HESM 1.71
  • MACD
  • ALKS -0.37
  • HESM -0.25
  • Stochastic Oscillator
  • ALKS 18.18
  • HESM 41.96

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About HESM Hess Midstream LP Share

Hess Midstream LP owns, operates, develops, and acquires a diverse set of midstream assets and provides fee-based services to Hess and third-party customers. It conducts its business through three operating segments: gathering, processing and storage, and terminaling and exporting. The company derives the maximum revenue from the gathering segment. Its gathering segment consists of the following assets namely Natural Gas Gathering and Compression; Crude Oil Gathering and Produced Water Gathering and Disposal.

Share on Social Networks: